Selected research
Industry Research
House Dust Mite Allergy Drugs Industry Research Report 2026
Market perspective
The global House Dust Mite Allergy Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for House Dust Mite Allergy Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for House Dust Mite Allergy Drugs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for House Dust Mite Allergy Drugs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of House Dust Mite Allergy Drugs include Zhejiang I-Biological Technology Co Ltd, Stallergenes Greer plc, Biomay AG, Anergis SA, Allergy Therapeutics Plc and ALK-Abello A/S, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global House Dust Mite Allergy Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
House Dust Mite Allergy Drugs Market by Company
Zhejiang I-Biological Technology Co Ltd
Stallergenes Greer plc
Biomay AG
Anergis SA
Allergy Therapeutics Plc
ALK-Abello A/S
House Dust Mite Allergy Drugs Segment by Type
PL-103
BM-35
AllerDM
Acarovac Quattro
Others
House Dust Mite Allergy Drugs Segment by Application
Hospital
Clinic
Others
House Dust Mite Allergy Drugs Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global House Dust Mite Allergy Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of House Dust Mite Allergy Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of House Dust Mite Allergy Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of House Dust Mite Allergy Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of House Dust Mite Allergy Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of House Dust Mite Allergy Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- PL-103
- BM-35
- AllerDM
- Acarovac Quattro
- Others
Applications
- Hospital
- Clinic
- Others
Companies covered
- Zhejiang I-Biological Technology Co Ltd
- Stallergenes Greer plc
- Biomay AG
- Anergis SA
- Allergy Therapeutics Plc
- ALK-Abello A/S
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global House Dust Mite Allergy Drugs Market Size (2021-2032)
- 2.2.2 Global House Dust Mite Allergy Drugs Sales (2021-2032)
- 2.2.3 Global House Dust Mite Allergy Drugs Market Average Price (2021-2032)
- 2.3 House Dust Mite Allergy Drugs by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 PL-103
- 2.3.3 BM-35
- 2.3.4 AllerDM
- 2.3.5 Acarovac Quattro
- 2.3.6 Others
- 2.4 House Dust Mite Allergy Drugs by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global House Dust Mite Allergy Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global House Dust Mite Allergy Drugs Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global House Dust Mite Allergy Drugs Revenue of Manufacturers (2021-2026)
- 3.4 Global House Dust Mite Allergy Drugs Average Price by Manufacturers (2021-2026)
- 3.5 Global House Dust Mite Allergy Drugs Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of House Dust Mite Allergy Drugs, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of House Dust Mite Allergy Drugs, Product Type & Application
- 3.8 Global Manufacturers of House Dust Mite Allergy Drugs, Established Date
- 3.9 Global House Dust Mite Allergy Drugs Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Zhejiang I-Biological Technology Co Ltd
- 4.1.1 Zhejiang I-Biological Technology Co Ltd Company Information
- 4.1.2 Zhejiang I-Biological Technology Co Ltd Business Overview
- 4.1.3 Zhejiang I-Biological Technology Co Ltd House Dust Mite Allergy Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Zhejiang I-Biological Technology Co Ltd House Dust Mite Allergy Drugs Product Portfolio
- 4.1.5 Zhejiang I-Biological Technology Co Ltd Recent Developments
- 4.2 Stallergenes Greer plc
- 4.2.1 Stallergenes Greer plc Company Information
- 4.2.2 Stallergenes Greer plc Business Overview
- 4.2.3 Stallergenes Greer plc House Dust Mite Allergy Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Stallergenes Greer plc House Dust Mite Allergy Drugs Product Portfolio
- 4.2.5 Stallergenes Greer plc Recent Developments
- 4.3 Biomay AG
- 4.3.1 Biomay AG Company Information
- 4.3.2 Biomay AG Business Overview
- 4.3.3 Biomay AG House Dust Mite Allergy Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Biomay AG House Dust Mite Allergy Drugs Product Portfolio
- 4.3.5 Biomay AG Recent Developments
- 4.4 Anergis SA
- 4.4.1 Anergis SA Company Information
- 4.4.2 Anergis SA Business Overview
- 4.4.3 Anergis SA House Dust Mite Allergy Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Anergis SA House Dust Mite Allergy Drugs Product Portfolio
- 4.4.5 Anergis SA Recent Developments
- 4.5 Allergy Therapeutics Plc
- 4.5.1 Allergy Therapeutics Plc Company Information
- 4.5.2 Allergy Therapeutics Plc Business Overview
- 4.5.3 Allergy Therapeutics Plc House Dust Mite Allergy Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Allergy Therapeutics Plc House Dust Mite Allergy Drugs Product Portfolio
- 4.5.5 Allergy Therapeutics Plc Recent Developments
- 4.6 ALK-Abello A/S
- 4.6.1 ALK-Abello A/S Company Information
- 4.6.2 ALK-Abello A/S Business Overview
- 4.6.3 ALK-Abello A/S House Dust Mite Allergy Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 ALK-Abello A/S House Dust Mite Allergy Drugs Product Portfolio
- 4.6.5 ALK-Abello A/S Recent Developments
5 Global House Dust Mite Allergy Drugs Market Scenario by Region
- 5.1 Global House Dust Mite Allergy Drugs Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global House Dust Mite Allergy Drugs Sales by Region: 2021-2032
- 5.2.1 Global House Dust Mite Allergy Drugs Sales by Region: 2021-2026
- 5.2.2 Global House Dust Mite Allergy Drugs Sales by Region: 2027-2032
- 5.3 Global House Dust Mite Allergy Drugs Revenue by Region: 2021-2032
- 5.3.1 Global House Dust Mite Allergy Drugs Revenue by Region: 2021-2026
- 5.3.2 Global House Dust Mite Allergy Drugs Revenue by Region: 2027-2032
- 5.4 North America House Dust Mite Allergy Drugs Market Facts & Figures by Country
- 5.4.1 North America House Dust Mite Allergy Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America House Dust Mite Allergy Drugs Sales by Country (2021-2032)
- 5.4.3 North America House Dust Mite Allergy Drugs Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe House Dust Mite Allergy Drugs Market Facts & Figures by Country
- 5.5.1 Europe House Dust Mite Allergy Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe House Dust Mite Allergy Drugs Sales by Country (2021-2032)
- 5.5.3 Europe House Dust Mite Allergy Drugs Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific House Dust Mite Allergy Drugs Market Facts & Figures by Country
- 5.6.1 Asia Pacific House Dust Mite Allergy Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific House Dust Mite Allergy Drugs Sales by Country (2021-2032)
- 5.6.3 Asia Pacific House Dust Mite Allergy Drugs Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America House Dust Mite Allergy Drugs Market Facts & Figures by Country
- 5.7.1 South America House Dust Mite Allergy Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America House Dust Mite Allergy Drugs Sales by Country (2021-2032)
- 5.7.3 South America House Dust Mite Allergy Drugs Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa House Dust Mite Allergy Drugs Market Facts & Figures by Country
- 5.8.1 Middle East and Africa House Dust Mite Allergy Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa House Dust Mite Allergy Drugs Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa House Dust Mite Allergy Drugs Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global House Dust Mite Allergy Drugs Sales by Type (2021-2032)
- 6.1.1 Global House Dust Mite Allergy Drugs Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global House Dust Mite Allergy Drugs Sales Market Share by Type (2021-2032)
- 6.2 Global House Dust Mite Allergy Drugs Revenue by Type (2021-2032)
- 6.2.1 Global House Dust Mite Allergy Drugs Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global House Dust Mite Allergy Drugs Revenue Market Share by Type (2021-2032)
- 6.3 Global House Dust Mite Allergy Drugs Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global House Dust Mite Allergy Drugs Sales by Application (2021-2032)
- 7.1.1 Global House Dust Mite Allergy Drugs Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global House Dust Mite Allergy Drugs Sales Market Share by Application (2021-2032)
- 7.2 Global House Dust Mite Allergy Drugs Revenue by Application (2021-2032)
- 7.2.1 Global House Dust Mite Allergy Drugs Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global House Dust Mite Allergy Drugs Revenue Market Share by Application (2021-2032)
- 7.3 Global House Dust Mite Allergy Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 House Dust Mite Allergy Drugs Value Chain Analysis
- 8.1.1 House Dust Mite Allergy Drugs Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 House Dust Mite Allergy Drugs Production Mode & Process
- 8.2 House Dust Mite Allergy Drugs Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 House Dust Mite Allergy Drugs Distributors
- 8.2.3 House Dust Mite Allergy Drugs Customers
9 Global House Dust Mite Allergy Drugs Analyzing Market Dynamics
- 9.1 House Dust Mite Allergy Drugs Industry Trends
- 9.2 House Dust Mite Allergy Drugs Industry Drivers
- 9.3 House Dust Mite Allergy Drugs Industry Opportunities and Challenges
- 9.4 House Dust Mite Allergy Drugs Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst